Literature DB >> 32197106

Evaluation of a tetravalent dengue vaccine by serostatus and serotype.

Annelies Wilder-Smith1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32197106     DOI： 10.1016/S0140-6736(20)30603-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Reconstructing long-term dengue virus immunity in French Polynesia.

Authors:  Takahiro Nemoto; Maite Aubry; Yoann Teissier; Richard Paul; Van-Mai Cao-Lormeau; Henrik Salje; Simon Cauchemez
Journal:  PLoS Negl Trop Dis       Date:  2022-10-03

Review 2.  Dengue vaccine development by the year 2020: challenges and prospects.

Authors:  Annelies Wilder-Smith
Journal:  Curr Opin Virol       Date:  2020-10-18       Impact factor: 7.090

3.  Integrated disease management: arboviral infections and waterborne diarrhoea.

Authors:  Hans J Overgaard; Nsa Dada; Audrey Lenhart; Thor Axel B Stenström; Neal Alexander
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.